Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants

Mol Diagn Ther. 2020 Aug;24(4):505. doi: 10.1007/s40291-020-00479-2.

¹ Surgical Research Laboratory, Institute of Cancer and Genomic Sciences, University of Birmingham, Vincent Drive, Birmingham, B15 2TT, UK.
² Queen Elizabeth Hospital Birmingham, Birmingham, UK.
³ Northern Devon Healthcare NHS Trust, Barnstaple, UK.
⁴ OncoDNA, Gosselies, Belgium.
⁵ PierianDx, St. Louis, MO, USA.
⁶ Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
⁷ Surgical Research Laboratory, Institute of Cancer and Genomic Sciences, University of Birmingham, Vincent Drive, Birmingham, B15 2TT, UK. a.beggs@bham.ac.uk.
⁸ Queen Elizabeth Hospital Birmingham, Birmingham, UK. a.beggs@bham.ac.uk.

Abstract

This article was originally published under a [CC BY NC 4.0] license.